HIV-1 sequences in lentiviral vector genomes can be substantially reduced without compromising transduction efficiency
Abstract Many lentiviral vectors used for gene therapy are derived from HIV-1. An optimal vector genome would include only the viral sequences required for transduction efficiency and gene expression to minimize the amount of foreign sequence inserted into a patient’s genome. However, it remains unc...
Guardado en:
Autores principales: | Helin Sertkaya, Mattia Ficarelli, Nathan P. Sweeney, Hannah Parker, Conrad A. Vink, Chad M. Swanson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9e4cd1425eb842c698f1446a5655b4b4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lentiviral vectors can be used for full-length dystrophin gene therapy
por: John R. Counsell, et al.
Publicado: (2017) -
Lentiviral vector induces high-quality memory T cells via dendritic cells transduction
por: Min Wen Ku, et al.
Publicado: (2021) -
Immunization of mice with lentiviral vectors targeted to MHC class II+ cells is due to preferential transduction of dendritic cells in vivo.
por: Séverine Ciré, et al.
Publicado: (2014) -
Cellular Proteo-Transcriptomic Changes in the Immediate Early-Phase of Lentiviral Transduction
por: Tamás Richárd Linkner, et al.
Publicado: (2021) -
Lentiviral transduction of CD34(+) cells induces genome-wide epigenetic modifications.
por: Yoshiaki Yamagata, et al.
Publicado: (2012)